CRISPR/Cas9-mediated genome editing of the thymidine kinase gene in a clinical HSV-1 isolate identifies F289S as novel acyclovir-resistant mutation

Saved in:
Bibliographic Details
Published in:Antiviral research 2024-08, Vol.228, p.105950, Article 105950
Main Authors: Zheng, Shuxuan, Verjans, Georges M.G.M., Evers, Anouk, van den Wittenboer, Ellen, Tjhie, Jeroen H.T., Snoeck, Robert, Wiertz, Emmanuel J.H.J., Andrei, Graciela, van Kampen, Jeroen J.A., Lebbink, Robert Jan
Format: Article
Language:English
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0166-3542
DOI:10.1016/j.antiviral.2024.105950